Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.31 Analyst target: $4.20 Upside: 220.61%
PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53 mutations in cancer. The company is headquartered in Cranbury, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.